Anzeige
Meldung des Tages: Breaking News: TeaRx™ erobert Großbritannien im Sturm?!

LakeShore Biopharma Aktie News

Aktie
WKN:  A40P1H ISIN:  KYG9845F2080 US-Symbol:  LSBCF Branche:  Biotechnologie Land:  China
0,1294 $
+0,00 $
0,00%
0,10984 € 17.02.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
100,00%
KGV
-
Index-Zuordnung
-

LakeShore Biopharma News

06.02.26 - PR Newswire
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders PR Newswire
20.01.26 - PR Newswire
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders PR Newswire
04.11.25 - PR Newswire
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
LakeShore Biopharma Enters into Definitive Agreement for Going-​Private Transaction PR Newswire
22.09.25 - PR Newswire
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting PR Newswire
12.09.25 - PR Newswire
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq PR Newswire
10.09.25 - PR Newswire
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee PR Newswire
28.08.25 - PR Newswire
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-​Binding Proposal to Acquire the Company and Formation of Special Committee PR Newswire
18.08.25 - PR Newswire
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
LakeShore Biopharma Announces Receipt of a Preliminary Non-​Binding Proposal to Acquire the Company PR Newswire
31.07.25 - PR Newswire
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results PR Newswire
08.07.25 - PR Newswire
LakeShore Biopharma Announces US$15 Million Private Placement Financing
LakeShore Biopharma Announces US$15 Million Private Placement Financing PR Newswire
23.04.25 - PR Newswire
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) PR Newswire

Newssuche

Videos

newspaper
18.02.26 -2,76%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
DiagnosTear Technologies Inc
0,268 €
+5,51%
DiagnosTear Technologies Inc Chart
TeaRx™ erobert Großbritannien im Sturm?!
Mehr zur Aktie »